A cascode configuration reduces reference modulation error in a 4-20 mA current mirror, improving active impedance by orders of magnitude.

The Australian sharemarket added 25.20 points or 0.29 per cent to 8,720.80, while the broader All Ordinaries gained 28.50 points or 0.32 per cent to 9,046.50. The technology sector advanced 1.72 per ...

Australian biopharmaceutical company CSL has designated China as one of its most important strategic markets worldwide, a milestone highlighted by a significant expansion of both its workforce and ...

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company announced in August ...

SYDNEY--Shares in Australia-based pharmaceutical company CSL tumbled 15% on Tuesday after the company delayed the spinoff of its flu vaccine unit and cut annual guidance. In late morning trade Tuesday ...

A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Australian biotechnology ...

Joy Linton, Chief Financial Officer of Australia's biotech company CSL talks about the company's restructuring, the impact of U.S. tariffs and currency volatility risks. Got a confidential news tip?

SYDNEY—Vaccine and blood-products company CSL on Tuesday unveiled a sweeping corporate restructure that will include spinning off its flu-vaccine unit Seqirus and cutting up to 15% of its staff.

Aug 19 (Reuters) - Australian biotech giant CSL (CSL.AX), opens new tab said on Tuesday it plans to demerge its influenza vaccine division, CSL Seqirus, into a separately listed company by the end of ...